leisure time -WSS

leisure time

author：Wikipedia 2025-10-01 18:34:50 - browse：64432

Daniel M. Skovronsky on stage at the 2023 STAT Summit. — Dan Skovronsky, Eli Lilly's chief scientific officer, at the 2023 STAT Summit. STAT

PHILADELPHIA — In a sense, the annual meeting of the American Heart Association wasn’t a huge one for Eli Lilly. Its biggest news was about a very early study of a drug to lower blood levels of Lp(a), a protein related to cholesterol that is mainly being watched by lipidologists and drug company analysts.

But in another way, the future of Lilly, now the biggest drug company by market capitalization, hung in the balance. Why? Because researchers were presenting data on the ability of Novo Nordisk’s obesity drug Wegovy to prevent heart attacks, strokes, and deaths in people with overweight who have established cardiovascular disease. That has big implications for the market for Lilly’s own obesity drug, Zepbound, which was approved by the Food and Drug Administration last week, and for the company’s future efforts in obesity.

STAT sat down with Lilly’s chief scientific officer, Dan Skovronsky, at the AHA meeting to talk about the obesity drugs known as GLP-1s, the new Lp(a) drug, and the company’s partnership with the gene editing firm Verve. An edited transcript of the conversation follows.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： H5N1 communication has been strictly for the birds

focus

WSS

First recipient of genetically engineered pig kidney has died

Feng Zhang CRISPR delivery startup lays off quarter of staff

Making AI in medicine accessible to smaller, and rural hospitals

3 medical device trends to watch in 2024

Researchers on aging grapple with how to calculate biological age

Making AI in medicine accessible to smaller, and rural hospitals

focus

leisure time

focus

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

How a scoliosis diagnosis changed the life of one young dancer

Novavax promises a turnaround & Lilly roils the obesity market

It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

Trump demands the U.S. pay no more for drugs than other countries … again

UCB departs biotech trade group BIO

Virginia high school admissions case could be legal follow

GSK Flovent asthma inhalers replaced by authorized generics

Apple is now the first public company to be valued at $3 trillion

H5N1 communication has been strictly for the birds

hotspot

GSK Flovent asthma inhalers replaced by authorized generics

Apple Watch's A

New weight loss drugs work. But how can they best be used?

White House finalizes ITC's import ban of latest Apple Watches

Federal weight loss drug coverage is 30 years out of date

Goldman Sachs launches $650M fund for life science investments

hotspot

entertainment

focus

hotspot